Anticoagulation

Front Matter....Pages i-xvii
Current trends in antithrombotic drug device development....Pages 1-15
Antithrombotic drugs....Pages 16-37
Heparin and non-heparin glycosaminoglycans: future perspectives for future applications....Pages 38-54
Antithrombotic activity of heparin and its derivatives: reliable and other putative mechanisms....Pages 55-118
Native antithrombin III, an activable protein....Pages 119-133
Antithrombotic potential of the medicinal leech saliva....Pages 134-146
Hirudin and hirudin fragments form the basis of new antithrombotics and anticoagulants....Pages 147-163
Perspectives of the Clinical use of Hirudin....Pages 164-176
The role of anti-myeloid series treatment in ischemic vascular disorders....Pages 177-219
Thrombomodulin — a novel anticoagulant....Pages 220-225
Anticoagulation for neonates, infants and children....Pages 226-247
Anticoagulation in the elderly: indications and limitations....Pages 248-269
Pregnancy and anticoagulation....Pages 270-278
Anticoagulation in pregnancy....Pages 279-298
Anticoagulants in pregnancy....Pages 299-308
Anticoagulant therapy and myocardial infarction....Pages 309-321
Anticoagulant therapy and atrial fibrillation....Pages 322-330
Anticoagulation and venous thrombosis....Pages 331-358
Antithrombotic post-operative treatment in recontructive arterial surgery....Pages 359-375
Anticoagulant therapy and heart valve prosthesis....Pages 376-380
Anticoagulation and coronary bypass grafts....Pages 381-390
Anticoagulants and orthopedic surgery....Pages 391-413
Hemostatic abnormalities, anticoagulation and anesthesia....Pages 414-445
Anticoagulation and Audiology....Pages 446-456
Use of anticoagulants and antithrombotics in dermatology....Pages 457-466
Anticoagulation and hepatocellular disfunction....Pages 467-482
Anticoagulation and the kidney....Pages 483-510
Haemorrhages and anticoagulants the responsibility of the patient....Pages 511-530